Nucala comes as an injection that you give under your skin. Nucala contains the active ingredient mepolizumab. (An active ingredient is what makes a drug work.) Nucala is available in three forms ...

Blue Cross is requiring at-home injection for severe asthma drugs in five states, raising concerns among doctors and patients ...

Blue Cross Blue Shield mandates severe asthma patients self-administer drugs at home, unless their provider gets prior approval from the company.

The change will affect several FDA-approved drugs, including Fasenra, Tezspire, Nucala, and Xolair ... why some patients prefer to receive these injections in a healthcare setting.

Given as injections, the treatments in question are Fasenra (benralizumab), Tezspire (tezepelumab), Nucala (mepolizumab) and Xolair (omalizumab). All belong to a class of drugs known as biologics.

The policy change affects asthma patients who rely on biologic medications like Fasenra, Tezspire, Nucala and Xolair ... Shield of Texas will treat asthma injection medications as pharmacy ...

as well as GSK’s follow-up to its severe asthma therapy Nucala showing value in a pair of phase 3 trials, reducing exacerbations compared to placebo with dosing once every six months.

Starting April 15, Blue Cross Blue Shield of Montana will require prior authorization for certain asthma injections in a clinic setting. The change will affect several FDA-approved drugs, including ...

Administered as a single injection, it represents a type of treatment using lab-made proteins known as monoclonal antibodies, which can cut off your body's allergic response at its source.